Management of Decreased Urine Output in Heart Failure

Initial Assessment and Management

The American College of Cardiology recommends distinguishing between two fundamentally different scenarios in patients with heart failure and decreased urine output: congestion with poor renal perfusion and true hypovolemia, with signs of congestion including elevated jugular venous pressure, peripheral edema, and orthopnea, indicating fluid overload requiring diuretics, not volume replacement 1.
The European Society of Cardiology suggests that key monitoring parameters during assessment include daily weights, fluid intake and output, serum electrolytes, BUN, and creatinine, with the goal of identifying patients who require diuretic therapy or cautious fluid administration 2, 3, 4.

The American College of Cardiology recommends initiating or escalating loop diuretics immediately in patients with congestion, with an initial IV dose that equals or exceeds the total daily oral dose, and adjusting the dose and duration based on symptoms and clinical response 2, 3, 1.
The European Society of Cardiology suggests that for diuretic-naive patients or those not on chronic diuretics, starting with furosemide 20-40 mg IV (or equivalent) is recommended, with bumetanide 0.5-1.0 mg IV or torsemide 10-20 mg IV as alternatives with better oral bioavailability 2, 3, 5, 6.

The American College of Cardiology recommends escalating diuretic therapy systematically if there is an inadequate response to moderate-dose loop diuretics, including increasing the loop diuretic dose, switching to IV administration, and adding a thiazide diuretic for sequential nephron blockade 5, 6.
The European Society of Cardiology suggests that common causes of diuretic resistance include high dietary sodium intake, NSAIDs blocking diuretic effects, and significant renal impairment, and that these should be addressed to optimize diuretic therapy 5, 6, 3.

The European Society of Cardiology recommends continuing guideline-directed medical therapy unless contraindicated, including maintaining ACE inhibitors/ARBs/ARNIs and beta-blockers in the absence of hemodynamic instability 3, 4, 1.
The American College of Cardiology suggests avoiding medications that worsen heart failure, including NSAIDs and COX-2 inhibitors, and thiazolidinediones (glitazones) 2, 3.

The European Society of Cardiology recommends daily assessments that include body weight, fluid intake and output, vital signs, clinical signs of perfusion and congestion, and serum electrolytes, BUN, and creatinine 2, 3, 4, 1.
The American College of Cardiology suggests targeting a weight loss of 0.5 to 1.0 kg daily during active diuresis until euvolemia is achieved 5, 7, 6.